IP Library Assignment 045886/0226
Patent Assignment
Reel/Frame 045886/0226

Assignment of Assignor's Interest

Recorded: 2018-05-23 Pages: 4
Assignor
SANDOZ GMBH
Executed: 2015-06-29
Assignee
SANDOZ AG
BIOCHEMIESTRASSE 10, KUNDL, 6250, AUSTRIA
Covered Property (1)
Selective Reduction of Cysteine Residues in Il-17 Antibodies
Application: 15/538,266 →
Publication: US 2017/0369567
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 23, 2018
From: HEITZMANN, MARKUS
To: NOVARTIS PHARMA AG
Reel/Frame 045885/0808 →
Assignment of Assignor's Interest May 23, 2018
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 045885/0921 →
Assignment of Assignor's Interest May 23, 2018
From: WINKLER, JOHANN
To: SANDOZ GMBH
Reel/Frame 045886/0023 →
Assignment of Assignor's Interest May 23, 2018
From: SANDOZ AG
To: NOVARTIS AG
Reel/Frame 045886/0320 →
Assignment of Assignor's Interest Jun 11, 2026
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 075712/0291 →